Results 171 to 180 of about 1,815,617 (316)

Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo [PDF]

, 1988
EN Dessypris, SE Graber, SB Krantz, WJ Stone   +3 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

H2valdien3 arrests the cell cycle and induces apoptosis of gastric cancer. [PDF]

Open Med (Wars)
Dang C, Ma S, Zhao X, Wang R, Liu R, Li H.   +5 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

CDC26 facilitates ferroptosis through SLC7A11 degradation and cell cycle arrest. [PDF]

Clin Exp Med
Lin J, Chen F, Tang H, Cai X, Huang M, Liang R, Kang R, Tang D, Liu J.   +8 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Enhancing cancer susceptibility to disulfidptosis by inducing cell cycle arrest and impairing DNA repair. [PDF]

Theranostics
Lin J, Yang X, Jiang C, Liu X, Shi J.
europepmc   +1 more source

Cellular responses to DNA damage: DNA repair, p53 induction, cell cycle arrest and apoptosis upon treatment of human cells with the carcinogen, anti-benzo(a)pyrene diol epoxide /

, 1996
Sundaresan Venkatachalam
openalex   +1 more source

Cell cycle-coupled transcriptional network orchestrates human B cell fate bifurcation [PDF]

Nicholas A. Pease, Jing‐Yu Fan, Swapnil Keshari, Jo Anne Stratton, Peter Gerges, Betsy Ann Varghese, Narayanan Nampoothiri VP, Christopher S. McGinnis, Wenxi Zhang, Steven B Gierlack, T. Raja Swaminathan, Ashish Sachan, Godhev Manakkat Vijay, Lídia Hernandez, Zarifeh Heidari Rarani, Camila Macedo, Diana Metes, Ansuman T. Satpathy, Abhinav K. Jain, Nidhi Sahni, Wayne Stallaert, Jishnu Das, Harinder Singh   +22 more
openalex   +1 more source

Cell cycle, cell division, cell death

Molecular Biology of the Cell, 2019
Maddox, Amy Shaub, Skotheim, Jan M.
openaire   +2 more sources